Health Italia SpA (FRA:6I50) EBIT: €4.98 Mil (TTM As of Jun. 2025)


FRA:6I50 Health Italia SpA FRA:6I50
60 GF Score
Price €296.00
GF Value €141.14
! 4 Warning Signs
View Full Analysis

What is Health Italia SpA EBIT?

Health Italia SpA FRA:6I50 60 EBIT is €4.98 Mil as of Jun. 2025. GuruFocus rates FRA:6I50 with a GF Score™ of 60/100 and a GF Value™ of €141.14. The stock has 4 warning signs investors should review.

Health Italia SpA's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2025 was €3.02 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2025 was €4.98 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Health Italia SpA's annualized ROC % for the quarter that ended in Jun. 2025 was 8.84%. Health Italia SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2025 was 20.78%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Health Italia SpA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2025 was 8.08%.


Health Italia SpA  (FRA:6I50) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Health Italia SpA's annualized ROC % for the quarter that ended in Jun. 2025 is calculated as:

ROC % (Q: Jun. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2024 ) + Invested Capital (Q: Jun. 2025 ))/ count )
=5.514 * ( 1 - 31.53% )/( (48.653 + 36.738)/ 2 )
=3.7754358/42.6955
=8.84 %

where

Note: The Operating Income data used here is two times the semi-annual (Jun. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Health Italia SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2024  Q: Jun. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=6.048/( ( (2.725 + max(32.884, 0)) + (2.738 + max(19.863, 0)) )/ 2 )
=6.048/( ( 35.609 + 22.601 )/ 2 )
=6.048/29.105
=20.78 %

where Working Capital is:

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(27.777 + 0 + 17.631) - (12.267 + 0 + 0.257)
=32.884

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(25.421 + 0 + 5.729) - (8.922 + 0 + 2.365)
=19.863

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Health Italia SpA's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2025 )
=4.984/61.707
=8.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Health Italia SpA EBIT Related Terms


Health Italia SpA EBIT Historical Data

* Premium members only.

The historical data trend for Health Italia SpA's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Italia SpA EBIT Chart

Health Italia SpA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.15 3.21 6.16 4.02 4.62

Health Italia SpA Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.47 1.55 2.66 1.96 3.02

FRA:6I50 vs UNH, CVS, CI: EBIT Comparison

For the Healthcare Plans subindustry, Health Italia SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health Italia SpA EV-to-EBIT vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Health Italia SpA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Health Italia SpA's EV-to-EBIT falls into.


FRA:6I50
60GF Score
Health Italia SpA FRA:6I50
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Health Italia SpA EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €4.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €4.98 Mil mean?
Health Italia SpA (FRA:6I50) has a EBIT of €4.98 Mil as of Jun. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Health Italia SpA.
Is Health Italia SpA's EBIT too high?
Health Italia SpA's current EBIT is €4.98 Mil. Overall, Health Italia SpA has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Health Italia SpA's EBIT compare to UNH and CVS?
Health Italia SpA's EBIT of €4.98 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Plans company?
A good EBIT depends on the Healthcare Plans industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Health Italia SpA. Health Italia SpA's current EBIT is €4.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Italia SpA stock overvalued right now?
Health Italia SpA (FRA:6I50) has a current EBIT of €4.98 Mil. The stock's GF Value™ is €141.14, compared to a current price of €296.00 — trading 109.7% above its estimated fair value. The current EBIT is €4.98 Mil. Health Italia SpA's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Health Italia SpA (FRA:6I50), the current EBIT is €4.98 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Health Italia SpA (FRA:6I50) Overvalued in 2026?

Based on GuruFocus' analysis, Health Italia SpA stock appears to be overvalued. The current stock price of €296.00 is trading 109.7% above its estimated GF Value™ of €141.14.

Key valuation signals for FRA:6I50:

  • EBIT: €4.98 Mil
  • GF Value™: €141.14 vs. price of €296.00 (109.7% above fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the FRA:6I50 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Health Italia SpA Business Description

Address Via di Santa Cornelia, 9, Formello, ITA, 00060
Health Italia SpA is an Italy based company engaged in offering integrated healthcare services. It operates in the promotion of integrated and alternative healthcare solutions and provides administrative, liquidation, information technology and consulting services for health funds, health care funds and mutual-aid companies. In addition, the group is also active in the corporate welfare market and manages outsourced flexible benefit welfare plans.
60GF Score

Get the complete analysis for FRA:6I50

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€296.00
Price
€141.14
GF Value